831191-83-4 Usage
Uses
Used in Organic Synthesis:
2-AMINO-3-(2,4-DIFLUOROPHENYL)PROPAN-1-OL is used as a building block in organic synthesis for the creation of various pharmaceutical and biological compounds. Its unique structure allows for the development of new molecules with potential applications in different fields.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2-AMINO-3-(2,4-DIFLUOROPHENYL)PROPAN-1-OL is used as a key intermediate in the synthesis of novel drugs and therapeutic agents. Its potential applications in medicinal chemistry make it a valuable compound for the development of innovative treatments and medications.
Used in Medicinal Chemistry:
2-AMINO-3-(2,4-DIFLUOROPHENYL)PROPAN-1-OL is utilized in medicinal chemistry for the design and synthesis of new drug candidates. Its unique properties and structure contribute to the advancement of drug discovery and the creation of effective therapeutic agents.
Used in Biochemistry:
In the field of biochemistry, 2-AMINO-3-(2,4-DIFLUOROPHENYL)PROPAN-1-OL is employed for studying the interactions between biological molecules and potential drug candidates. This helps in understanding the mechanisms of action and improving the efficacy of new drugs.
Check Digit Verification of cas no
The CAS Registry Mumber 831191-83-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,3,1,1,9 and 1 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 831191-83:
(8*8)+(7*3)+(6*1)+(5*1)+(4*9)+(3*1)+(2*8)+(1*3)=154
154 % 10 = 4
So 831191-83-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H11F2NO/c10-7-2-1-6(9(11)4-7)3-8(12)5-13/h1-2,4,8,13H,3,5,12H2
831191-83-4Relevant articles and documents
Synthesis of chiral building blocks for use in drug discovery
Marino, Sharon T.,Stachurska-Buczek, Danuta,Huggins, Daniel A.,Krywult, Beata M.,Sheehan, Craig S.,Nguyen, Thao,Choi, Neil,Parsons, Jack G.,Griffiths, Peter G.,James, Ian W.,Bray, Andrew M.,White, Jonathan M.,Boyce, Rustum S.
, p. 405 - 426 (2007/10/03)
In the past decade there has been a significant growth in the sales of pharmaceutical drugs worldwide, but more importantly there has been a dramatic growth in the sales of single enantiomer drugs. The pharmaceutical industry has a rising demand for chiral intermediates and research reagents because of the continuing imperative to improve drug efficacy. This in turn impacts on researchers involved in preclinical discovery work. Besides traditional chiral pool and resolution of racemates as sources of chiral building blocks, many new synthetic methods including a great variety of catalytic reactions have been developed which facilitate the production of complex chiral drug candidates for clinical trials. The most ambitious technique is to synthesise homochiral compounds from non-chiral starting materials using chiral metal catalysts and related chemistry. Examples of the synthesis of chiral building blocks from achiral materials utilizing asymmetric hydrogenation and asymmetric epoxidation are presented.
